These findings indicate that the pro-obesity effects of peripherally applied NT4 are not mediated by receptor down-regulation and that peripheral NT4 administration may directly reduce metabolic rate independent of its effect on food intake in the nonhuman primates. The gene discussed is NTF4; the disease is obesity disorder.